{"name":"Stem Med Pte. Ltd.","slug":"stem-med-pte-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Autologous BM MSC","genericName":"Autologous BM MSC","slug":"autologous-bm-msc","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Autologous BM MSC","genericName":"Autologous BM MSC","slug":"autologous-bm-msc","phase":"phase_3","mechanism":"Autologous bone marrow-derived mesenchymal stem cells (BM MSCs) are harvested from the patient's own bone marrow and administered to promote tissue repair and modulate immune responses.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQWlZUV3ZBYlJhSk5vZVMxdVd4dVVINmk2TDQ1cFNKMS1vZDRwcHFESHZRcmNyZXI2UHV6dFBhU1lFS0t5SDNFTGpEREQ1SWFtR2YxYXNZMEdLOFJHVHNvTkhtc2JXbHFPSHNfM3FENnhhbGQxN2ZIemRBQmFEOVVobDR0VGMycUtRd1J4U0d5c2VCb2VOVWpaOEZ3?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Key Factors and Emerging Trends Shaping the Adipose Tissue Derived Stem Cell Market Landscape - openPR.com","headline":"Key Factors and Emerging Trends Shaping the Adipose Tissue Derived Stem Cell Market Landscape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxOWmpwVWtJVkcwSFhhSDJYTVNEanJBVHhsWE9ZYnhZUnRubHpiUHhpNnlfYUhhRHdNYmZOZXRNLXBKb0ZZS0MycHNNRXJ0QXlMSE1EdDdHZjNObDdTNHV5QWhoVkFnRXQ0aWh5NXYtTkVJUVMzSjVud0tveEZIeEd0RkdxR3BwSlN1YVNsNUItcXR2cEpzR0IwR2ZyNXNFTnJ4TnZIRHJRNWZDMXBXLVIxYnhsRkE0UFh3Z0hoOEwwSS1jbUQ0NzEzR0Z6SXZEd3JKMEY0U0VscEhPeFVQZDZhSzZlc05Ga0Ezc0cyTGp4NW5uRzNweW0zQnE1cG9DSzN4dU1mMUpmT3pHM3ZOQ0MzdEJTQy1BdDU1WDFpMGRvbWg4ZEV3aUJwaV83ZjhmbXJvSHM1Rzk0dk4?oc=5","date":"2026-03-31","type":"regulatory","source":"The Norfolk Daily News","summary":"Stem Cell Therapy Market to Reach $615 Million as Clinical Advancements and Regenerative Medicine Demand Accelerate - The Norfolk Daily News","headline":"Stem Cell Therapy Market to Reach $615 Million as Clinical Advancements and Regenerative Medicine Demand Accelerate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPdU10a3JqWDBiNjlzOW9MemJPNko1NzZaMEplVkxfZXRVS2plaTljNGJ5RUlybmpJaTRFMVVVVGxsRmRiTDVURGpZczZrVnBaV25BV2ZPbnJ0akNVa2V4MVJSSGx4a1RmcDV4TzN5VkhOR3ppMWpXckpUWEpOejRscWdyNDJOOHdCRG93aTZDeU8?oc=5","date":"2026-03-11","type":"trial","source":"Market Data Forecast","summary":"Induced Pluripotent Stem Cells Market Size Report, 2034 - Market Data Forecast","headline":"Induced Pluripotent Stem Cells Market Size Report, 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE10RzhyX2tKYWllYVBBMzBnam5LRkhyX3hZLXVPZ01GLTJSTE1oeGhIcGJNcmV2MzQ0N3AxVTVEeVpfNjBxU3hMME1PWmZvLWxNekRvS0xn?oc=5","date":"2026-03-06","type":"regulatory","source":"朝日新聞","summary":"Japan approves world‑first iPS cell drugs for summer release - 朝日新聞","headline":"Japan approves world‑first iPS cell drugs for summer release - 朝日新聞","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1IWGt0aHk5LV9Ra2l3Z2FqQXB5am1RODZZaVIydHJvM2ZMX2R6bFJ4R0VGWjAwU25CdkYzY1VocnAwcGpTcnJTNXhYVU9zanB6Sk5pbE9NVk1OMURLeHM3VEdkWGRlcnPSAWxBVV95cUxOV05WRWNUVmU1Zy1QRzNXQlBwQjlUb2xieU91ekx1SmNQcXEwQ2dxVkxtaThLd21uUzFiaE1pWEVZVVJ3dUQ1RjNTelpyb3hyLVlHa3ZyT3Y5c0ZTQUM2MFRaTFNEYkp2X2E0N3c?oc=5","date":"2026-03-05","type":"pipeline","source":"BioInformant","summary":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant","headline":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQSzV6aTFpUDZrYkhtNUFoOWpBYjRxRkxCOF9FTmNvQWpPX21Fb2N3dC1QSlc5U1RoalZ4aVBLQXdWSVZKZUpCVGlYblBPV1dBOWdtRl95S2g4dmRqeUtHNGRzSURSRFRKQVpvQmxseEh2Z0lRZmpWOE8wTGtMdEE4ajU1aDVMdkh2TzU4MGpZUGJvSjZ1cEhGb0pNSERDZnNaY0pteTN4aU93dk9NLU9Z?oc=5","date":"2026-02-19","type":"pipeline","source":"Bloomberg.com","summary":"Japan’s Regenerative Cell Therapy Push Faces Crucial Review - Bloomberg.com","headline":"Japan’s Regenerative Cell Therapy Push Faces Crucial Review","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNQ0k3OU9jY0wzTjZ4ODFMOUFfTFJqRW5RbzVwajJYNVZ3WGZDTXVvSHh4b245VzhRTS1WTmhsQ3Z0REpDcGQ5RjUyMVJ6Z0FzSmlxLWlFWFkyNjR2Q1pOWnNMY1ZpX1R3dDUzTXRFRkg1RW5sTHFJMU15QldLYmxtc3pKcEh6a1k?oc=5","date":"2026-02-19","type":"pipeline","source":"The Japan Times","summary":"Japan panel OKs medical products using iPS cells - The Japan Times","headline":"Japan panel OKs medical products using iPS cells","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOekExOVpFM1BwQ2ZFbDV4MVc3d3JxN2dwVHppQjNBbXhjUy1yeWlHaVk2UDdZVzc1MmtHS1BkVno0MXZuVDRxWmd4N0lrb3FZMG91NFJYU3FnXzE1VUFzUWhwcDZGV3NYSzJ0TFowbEotU3MtQ2hiZHJmcHBwT09Db2l1QXpENkY5ellXUEJkdmxGY0RLMmprZ2JORkw2b0RIRWI3Wi12MFU?oc=5","date":"2026-02-19","type":"pipeline","source":"Bloomberg.com","summary":"Sumitomo Pharma Shares Drop After Stem-Therapy Backing - Bloomberg.com","headline":"Sumitomo Pharma Shares Drop After Stem-Therapy Backing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNTG13VHNDZ0FmRVExQjRWQmJmVFFsY2xnREp1ZVAzTlJpZEpFOUZCbnRUZllRcHJlckR5cDJ5V29DbFphenFtU2dfa2R2OUxNYlRxYkFuaDNjbUJEYjFRekVfNGNMZnp6UG9pUUg1Zm9QUVZmaGh5MjB3TkZyTFdyVGZiQzM3cmV4NHRBQ1dIVDBiY1lVOVZTT19YbllRZHVaYVZJZE1zbV9JcndQbTkyWlRyeVl2V091a3ExX3pXVUZyODhzbFFDWWZXdmZyWU41bjZNelRRZU1mR1FEYVM4cVBPYWRWTDhGMEQ0SUkxNUNTV2I1SURGOWEtUHl0a1QyNGlsV0hxMmZocEdrWEpvUmpKNF9ibUMwUnVCSFplNWdSQjkwNndhRFBNc1dEMTVaTjZuX3h3NA?oc=5","date":"2025-11-11","type":"deal","source":"Business Wire","summary":"Induced Pluripotent Stem Cells (iPSCs) Market Prospects 2025-2033: Industry Gains Traction with Rising Investments and Collaborations - ResearchAndMarkets.com - Business Wire","headline":"Induced Pluripotent Stem Cells (iPSCs) Market Prospects 2025-2033: Industry Gains Traction with Rising Investments and C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxNYUxUODZSMUNzWjg2a2hJbUE4M0pIOVVtcjZyNWFBTVU1ZWVvUkNLMEk2eG1PQm5xdG1mLTczMmxkNU5QNlM0TE9fX21NM2pIVnBCel9SUmp0NDhOQUpuVndtVDhUbXVJcm13aTl5Z0tPY3hldElIZFphS3BTcGVvMmFYSlVrM19NWExtWXc0cEVEZzNMNTJ4T3hGWU5ETFhlYWxDRTlvVllJS3Q0Sm41YjFLZWFXT2NzaVUyd1dkaF9JcERtZVBiMnRULWZnYldxZEN3YVhhWDJIU3BtcjJJUUljNkp1S0pDbGFrWWZMMjE4dUtvcjIwZjlBRDZPN3dYQnN4VUxjU2lsQjd6ZGlNSEU5aXFST0pLZTJBSmplOUliTnhIQnc4?oc=5","date":"2025-09-17","type":"pipeline","source":"GlobeNewswire","summary":"Regenerative Medicine Market Size Worth USD 1,69,586 Mn by - GlobeNewswire","headline":"Regenerative Medicine Market Size Worth USD 1,69,586 Mn by","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOOEVpcy1BTVpvNDEtTW9vNHBCSmZOYXZTOUlJaWE4ck5oTlRlTnBLZDRVNko4WmU1SGVBUW9ZRWxOdWxwRmpBWThIVE1kNm1XLWZnbTlZYkpOMnFMZXR4a2h0WTJVcTJHVmJWVDhEMDZQOGpDRFZOY0lvY1VLb2JRanZ4U1d5MFVqRGs3SkREczRIa01XYnlXNF8tbWVXT3dKTXRJTkhmRmpQNS11SUliV0Nfak5WNzlHbmZGbkVycURrZ0RQb2QzVmljRkxJV2RKN0xrQ1ZkVW1HVlo5Yi1US0xWeGJBLUVTRGlVeUxfem9wbVNRN01jNjNpUVB2VXhF?oc=5","date":"2025-08-07","type":"pipeline","source":"BioSpace","summary":"Stem Cell Therapy Market Size to Hit USD 78.39 Billion by 2032, Growing at a CAGR of 22.8% from 2025 to 2032 | Coherent Market Insights - BioSpace","headline":"Stem Cell Therapy Market Size to Hit USD 78.39 Billion by 2032, Growing at a CAGR of 22.8% from 2025 to 2032 | Coherent ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5Hc2twLUtwLWpkU0FkTVZhNzlqZEhuQS0wVm9qTUN5ckQ4bWVYSWZpQVdqWXlhNnFSVWxIalhtZ21NUDRhME5YNmNMOHZYa0ZHa2lsa0E1SFplZWZUWkJj?oc=5","date":"2025-07-01","type":"pipeline","source":"nature.com","summary":"Bioengineered chondrocyte-products from human induced pluripotent stem cells are useful for repairing articular cartilage injury in minipig model - nature.com","headline":"Bioengineered chondrocyte-products from human induced pluripotent stem cells are useful for repairing articular cartilag","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}